These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 14626883)

  • 1. The duty of the pharmacist and the pharmaceutical industry.
    Dwyer P
    Med Law; 2003; 22(3):495-516. PubMed ID: 14626883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacist liability.
    Sveska KJ
    Am J Hosp Pharm; 1993 Jul; 50(7):1429-36. PubMed ID: 8362880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bad medicine: prescription drugs, preemption, and the potential for a no-fault fix.
    Smirniotopoulos A
    Rev Law Soc Change; 2012; 35(4):793-862. PubMed ID: 22363960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent developments in pharmaceutical products liability law: failure to warn, the learned intermediary defense, and other issues in the new millennium.
    Garbutt BJ; Hofmann ME
    Food Drug Law J; 2003; 58(2):269-86. PubMed ID: 12866558
    [No Abstract]   [Full Text] [Related]  

  • 5. Reimagining the learned intermediary rule for the new pharmaceutical marketplace.
    Hall TS
    Seton Hall Law Rev; 2004; 35(1):193-261. PubMed ID: 15614980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whose liability is it? The pharmacist on trial.
    Am Pharm; 1994; NS34 Suppl 1():1-16; quiz 17-9. PubMed ID: 7726096
    [No Abstract]   [Full Text] [Related]  

  • 7. Unlabeled drug samples and the learned intermediary: the case for drug company liability without preemption.
    Poser S
    Food Drug Law J; 2007; 62(4):653-94. PubMed ID: 18557225
    [No Abstract]   [Full Text] [Related]  

  • 8. Disease-branding and drug-mongering: could pharmaceutical industry promotional practices result in tort liability?
    Cetel JS
    Seton Hall Law Rev; 2012; 42(2):643-702. PubMed ID: 22708139
    [No Abstract]   [Full Text] [Related]  

  • 9. Tort claims and federal regulation of medical devices vs pharmaceuticals.
    Green M
    JAMA; 2009 Sep; 302(11):1169; author reply 1169-70. PubMed ID: 19755694
    [No Abstract]   [Full Text] [Related]  

  • 10. Prescription drugs, products liability, and preemption of tort litigation.
    DeAngelis CD; Fontanarosa PB
    JAMA; 2008 Oct; 300(16):1939-41. PubMed ID: 18940985
    [No Abstract]   [Full Text] [Related]  

  • 11. [The criminal liability of the hospital pharmacist vs the liability of the hospital].
    Siracusa M; Grappasonni I; Petrelli F
    Recenti Prog Med; 2016 Jan; 107(1):19-24. PubMed ID: 26901366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Legal liability in clinical trials from the legal-pharmaceutical viewpoint].
    Amon F
    Z Arztl Fortbild (Jena); 1995 Nov; 89(6):638-41. PubMed ID: 8588437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Strict liability and development risk exemption in the pharmaceutical sector].
    Lerat R
    Ann Pharm Fr; 2000 Dec; 58(6 Suppl):499-504. PubMed ID: 11148389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hospital liability for accuracy of pharmacist consultations.
    Brushwood DB; Nanni KR
    Am J Health Syst Pharm; 2009 Apr; 66(7):680-3. PubMed ID: 19299377
    [No Abstract]   [Full Text] [Related]  

  • 15. The Omnibus Reconciliation Act of 1990: redefining pharmacists' legal responsibilities.
    Huang SW
    Am J Law Med; 1998; 24(4):417-42. PubMed ID: 9876784
    [No Abstract]   [Full Text] [Related]  

  • 16. The federal preemption debate in pharmaceutical labeling product liability actions.
    Gross JM; Curry JA
    Tort Trial Insur Pract Law J; 2007; 43(1):35-70. PubMed ID: 18354866
    [No Abstract]   [Full Text] [Related]  

  • 17. FDA attempting to overcome major roadblocks in monitoring drug safety.
    Zielinski SL
    J Natl Cancer Inst; 2005 Jun; 97(12):872-3. PubMed ID: 15956645
    [No Abstract]   [Full Text] [Related]  

  • 18. Permitting product liability litigation for FDA-approved drugs and devices promotes patient safety.
    Kesselheim AS
    Clin Pharmacol Ther; 2010 Jun; 87(6):645-7. PubMed ID: 20485322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shared liability? Consultants, pharmacists, and the emergency physician: legal cases and caveats.
    Moore JJ; Matlock AG
    J Emerg Med; 2014 May; 46(5):612-6. PubMed ID: 24462033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can a physician sue a pharmaceutical manufacturer when a drug harms a patient?
    Cacciatore GG
    Tex Med; 1997 Mar; 93(3):62-4. PubMed ID: 9062462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.